Skip to main content
. 2014 Jul 3;9:53–60. doi: 10.4137/BMI.S16199

Figure 1.

Figure 1

Identification and detection of the differential methylation at the two novel sites in the MED15/PCQAP promoter. (A) Schematic showing location of the sites in the main promoter-associated CpG island. (B) Sequence of the two regions in the MED15/PCQAP promoter illustrating tumor-associated hypermethylation at the two CpG clusters (yellow and green) present in samples of tested subjects (results from three patients’, P1–P3, shown). Please note that the reference sequence assumes full methylation at the CG dinucleotides.